ArticleThrombosis journal2023

Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis.

JongSung Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.